These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1906098)

  • 21. Zidovudine and other drugs against HIV.
    Drug Ther Bull; 1988 Dec; 26(26):101-4. PubMed ID: 3065024
    [No Abstract]   [Full Text] [Related]  

  • 22. Polymyositislike syndromes in acquired immunodeficiency syndrome.
    Curtis M; Gill MJ; Brownell AK
    Arch Neurol; 1989 Aug; 46(8):841. PubMed ID: 2757521
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuromuscular complications of human immunodeficiency virus infection and antiretroviral therapy.
    Miller RG
    West J Med; 1994 May; 160(5):447-52. PubMed ID: 8048229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.
    Chen SC; Barker SM; Mitchell DH; Stevens SM; O'Neill P; Cunningham AL
    Pathology; 1992 Apr; 24(2):109-11. PubMed ID: 1641255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postural hypotension related to zidovudine in a patient infected with HIV.
    Loke RH; Murray-Lyon IM; Carter GD
    BMJ; 1990 Jan; 300(6718):163-4. PubMed ID: 2105796
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of pharmacokinetics, safety, tolerance, and activity of combination of zalcitabine and zidovudine in stable, zidovudine-treated pediatric patients with human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 190 Team.
    Bakshi SS; Britto P; Capparelli E; Mofenson L; Fowler MG; Rasheed S; Schoenfeld D; Zimmer B; Frank Y; Yogev R; Jimenez E; Salgo M; Boone G; Pahwa SG
    J Infect Dis; 1997 May; 175(5):1039-50. PubMed ID: 9129064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematologic toxicity of zidovudine in HIV-infected patients.
    Brogan KL; Zell SC
    Am Fam Physician; 1990 May; 41(5):1521-8. PubMed ID: 1692180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine.
    Herzberg NH; Zorn I; Zwart R; Portegies P; Bolhuis PA
    Muscle Nerve; 1992 Jun; 15(6):706-10. PubMed ID: 1324428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skeletal muscle involvement in HIV-infected patients.
    Gherardi RK
    Neuropathol Appl Neurobiol; 1994 Jun; 20(3):232-7. PubMed ID: 7936072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P; Monnet I; Gherardi R
    Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period.
    Blanche S; Duliege AM; Navarette MS; Tardieu M; Debré M; Rouzioux C; Seldrup J; Kouzan S; Griscelli C
    Pediatrics; 1991 Aug; 88(2):364-70. PubMed ID: 1861941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zidovudine-induced anaemia in HIV/AIDS.
    Sharma SK
    Indian J Med Res; 2010 Oct; 132():359-61. PubMed ID: 20966512
    [No Abstract]   [Full Text] [Related]  

  • 34. Coma during azidothymidine therapy for AIDS.
    Riedel RR; Clarenbach P; Reetz KP
    J Neurol; 1989 Mar; 236(3):185. PubMed ID: 2709071
    [No Abstract]   [Full Text] [Related]  

  • 35. Zidovudine-related myopathy.
    Daniels DG; McCormack SM; McLean KA; Davies PT; Lane RJ
    Lancet; 1990 Nov; 336(8725):1256. PubMed ID: 1978099
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.
    Fischl MA; Richman DD; Causey DM; Grieco MH; Bryson Y; Mildvan D; Laskin OL; Groopman JE; Volberding PA; Schooley RT
    JAMA; 1989 Nov; 262(17):2405-10. PubMed ID: 2677429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombocytopenia in children infected with human immunodeficiency virus: long-term follow-up and therapeutic considerations.
    Rigaud M; Leibovitz E; Quee CS; Kaul A; Nardi M; Pollack H; Lawrence R; DiJohn D; Krasinski K; Karpatkin M
    J Acquir Immune Defic Syndr (1988); 1992; 5(5):450-5. PubMed ID: 1560341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zidovudine regimen in pediatric AIDS trial halted, other regimens shown superior.
    Am J Health Syst Pharm; 1995 May; 52(9):932. PubMed ID: 7641031
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV or zidovudine myopathy?
    Kieburtz K
    Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309596
    [No Abstract]   [Full Text] [Related]  

  • 40. AZT indication extended to use in children.
    J Am Osteopath Assoc; 1990 Jan; 90(1):16, 19. PubMed ID: 2312366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.